Home » Videos » News18 Shorts » AstraZeneca's Vaccine Trials Resume in UK, Indian Trials to Begin Post DCGI Approval

AstraZeneca's Vaccine Trials Resume in UK, Indian Trials to Begin Post DCGI Approval

Sep 13, 2020 03:49 PM IST India India
Share

Pharmaceutical giant AstraZeneca has resumed UK clinical trials of its COVID-19 vaccine. AstraZeneca who is working with University of Oxford said MHRA confirmed it is safe to resume British trials.

Loading